3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Lung Neoplasms
28
Ovarian Neoplasms
27
Fallopian Tube Neoplasms
24
Carcinoma, Non-Small-Cell Lung
21
Colorectal Neoplasms
17
Pancreatic Neoplasms
11
Glioblastoma
11
Melanoma
10
Carcinoma, Renal Cell
10
Carcinoma, Hepatocellular
10
Breast Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Lymphoma, Large B-Cell, Diffuse
8
Urinary Bladder Neoplasms
7
Neoplasm Metastasis
7
Colonic Neoplasms
7
Brenner Tumor
7
Uterine Cervical Neoplasms
6
Rectal Neoplasms
6
Prostatic Neoplasms
6
Mycosis Fungoides
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Brain Neoplasms
6
Triple Negative Breast Neoplasms
5
Multiple Myeloma
5
Lymphoma, T-Cell, Cutaneous
5
Sezary Syndrome
4
Sarcoma
4
Neoplasms
4
Nasopharyngeal Carcinoma
4
Interventions
Doxorubicin
25
Radiotherapy
16
Ifosfamide
14
Trabectedin
10
pazopanib
6
ribociclib
5
pembrolizumab
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Gemcitabine
5
Biopsy
5
palbociclib
4
Radiation
4
Docetaxel
4
Chemotherapy, Adjuvant
4
selinexor
3
liposomal doxorubicin
3
eribulin
3
abemaciclib
3
X-Rays
3
Vincristine
3
Neoadjuvant Therapy
3
Imatinib Mesylate
3
Filgrastim
3
Etoposide
3
Cyclophosphamide
3
toripalimab
2
temsirolimus
2
romidepsin
2
pegfilgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liposarcoma
×
Disulfides
×
Clear all
NCT04668300
2026-04-15
DOSa
M.D. Anderson Cancer Center
Phase 2
Active not recruiting
75 enrolled